Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease (Q45746926)

15 December 2017

title

Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease (English)

1 reference

15 December 2017

Kundi M

1 reference

15 December 2017

Aberle JH

1 reference

15 December 2017

Aberle SW

1 reference

15 December 2017

Dworzak MN

1 reference

15 December 2017

Mandl CW

1 reference

15 December 2017

Rebhandl W

1 reference

15 December 2017

Vollnhofer G

1 reference

15 December 2017

Popow-Kraupp T

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

15 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

15 December 2017

volume

160

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

1263-1268

1 reference

15 December 2017

The respiratory syncitial virus and its role in acute bronchiolitis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Sequelae of respiratory syncytial virus infections. A role for intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Respiratory Syncytial Virus Infection in Infants Is Associated with Predominant Th-2-like Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Respiratory Viruses Induce Production of Histamine-Releasing Factor by Mononuclear Leukocytes: A Possible Role in the Mechanism of Virus-Induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay, indirect immunofluorescence, and virus isolation: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Recent observations regarding the pathogenesis of recurrent respiratory syncytial virus infections: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

A distinctive pattern of B cell immaturity in perinatal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.4.9812025

10.1164/AJRCCM.160.4.9812025

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017